• Profile
Close

Ovarian hyperandrogenism and its response to gonadotropin-releasing hormone analogue therapy in primary severe insulin resistance

Journal of Clinical Endocrinology and Metabolism Apr 29, 2021

Huang-Doran I, Kinzer AB, Jimenez-Linan M, et al. - In the present study, the researchers sought to characterise hyperandrogenemia and ovarian pathology in primary severe insulin resistance (SIR), using insulin resistance of defined molecular etiology to interrogate disease mechanism, as well as to extend the evaluation of gonadotropin-releasing hormone (GnRH) analogue therapy in SIR. Participants in the study were female patients with SIR with documented serum total testosterone concentration. Whether due to proximal insulin signaling or adipose development defects, SIR induces severe hyperandrogenemia and polycystic ovary syndrome-like ovarian changes. Sex hormone binding globulin mediates a distinct relationship between IR and free testosterone between the groups. In a range of SIR subphenotypes, GnRH analogues are useful.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay